GenSight Biologics raises EUR 32M in series A

GenSight Biologics Inc. (Paris, France) raised EUR 32 million ($41.6 million) in a series A round co-led by Novartis Venture Fund; Abingworth; Versant Ventures; and Index Ventures. GenSight's lead pro...